Literature DB >> 34306408

Investigation of the value of carotid-femoral pulse wave velocity and coronary artery lesions in prognosis of percutaneous coronary intervention patients.

Yulin Fang1, Qiuying Zhong2.   

Abstract

OBJECTIVE: To investigate the value of carotid-femoral pulse wave velocity (CFPWV) and coronary artery lesions in assessing prognosis of percutaneous coronary intervention (PCI) patients.
METHODS: A total of 300 PCI patients admitted to our hospital were selected as study subjects, and were divided into Group A (0-13 m/s, n=180) and Group B (> 13 m/s, n=120) in accordance with different carotid-femoral pulse wave velocities (CFPWVs). Coronary artery lesions, incidence rates of major adverse cardiac events (MACE) at different stages, and differences in the indexes of cardiac function were compared between the two groups.
RESULTS: Compared to Group A, Group B had more severe coronary artery lesions and higher incidence rates of postoperative complications and MACE during hospital stay and 2-year follow-up (P < 0.05). At 1 month after surgery, the left ventricular stroke volume, left ventricular end-diastolic volume and left ventricular ejection fraction in Group A were higher than those of Group B. CFPWV was significantly correlated with Gensini score (GS) and incidence rate of MACE (P < 0.05), and the differences in the area under curve (AUC) of CFPWV for predicting the incidence rate of MACE were significant (P < 0.05).
CONCLUSION: CFPEV, exhibits value in assessing the prognosis of PCI patients, and can effectively predict the postoperative incidence of MACE, which is conducive to the establishment of subsequent regimens. Therefore, CFPEV is worthy of clinical promotion and implementation. AJTR
Copyright © 2021.

Entities:  

Keywords:  CFPWV; PCI; assessment of prognosis; coronary artery lesions; value

Year:  2021        PMID: 34306408      PMCID: PMC8290781     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  25 in total

1.  Long-term clinical outcomes of transient and persistent no-reflow following percutaneous coronary intervention (PCI): a multicentre Australian registry.

Authors:  Stavroula Papapostolou; Nick Andrianopoulos; Stephen J Duffy; Angela L Brennan; Andrew E Ajani; David J Clark; Christopher M Reid; Melanie Freeman; Martin Sebastian; Laura Selkrig; Matias B Yudi; Samer Q Noaman; William Chan
Journal:  EuroIntervention       Date:  2018-06-20       Impact factor: 6.534

2.  Oxygen Therapy in Suspected Acute Myocardial Infarction.

Authors:  Robin Hofmann; Leif Svensson; Stefan K James
Journal:  N Engl J Med       Date:  2018-01-11       Impact factor: 91.245

Review 3.  Percutaneous coronary intervention for the left main stem and other bifurcation lesions: 12th consensus document from the European Bifurcation Club.

Authors:  Jens Flensted Lassen; Francesco Burzotta; Adrian P Banning; Thierry Lefèvre; Olivier Darremont; David Hildick-Smith; Alaide Chieffo; Manuel Pan; Niels Ramsing Holm; Yves Louvard; Goran Stankovic
Journal:  EuroIntervention       Date:  2018-01-20       Impact factor: 6.534

Review 4.  Management of percutaneous coronary intervention complications.

Authors:  Sri Raveen Kandan; Thomas William Johnson
Journal:  Heart       Date:  2018-05-14       Impact factor: 5.994

5.  Circulating Long Noncoding RNA HOTAIR is an Essential Mediator of Acute Myocardial Infarction.

Authors:  Lu Gao; Yuan Liu; Sen Guo; Rui Yao; Leiming Wu; Lili Xiao; Zheng Wang; Yuzhou Liu; Yanzhou Zhang
Journal:  Cell Physiol Biochem       Date:  2017-12-01

6.  Timing of percutaneous coronary intervention in patients with non-ST-elevation myocardial infarction: a SWEDEHEART study.

Authors:  Daniel Lindholm; Joakim Alfredsson; Oskar Angerås; Felix Böhm; Fredrik Calais; Sasha Koul; Bo Lagerqvist; Henrik Renlund; Giovanna Sarno; Christoph Varenhorst
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2017-01-01

Review 7.  Percutaneous coronary intervention in left main coronary artery disease: the 13th consensus document from the European Bifurcation Club.

Authors:  Francesco Burzotta; Jens Flensted Lassen; Adrian P Banning; Thierry Lefèvre; David Hildick-Smith; Alaide Chieffo; Olivier Darremont; Manuel Pan; Yiannis S Chatzizisis; Remo Albiero; Yves Louvard; Goran Stankovic
Journal:  EuroIntervention       Date:  2018-05-20       Impact factor: 6.534

Review 8.  Reducing the Global Burden of Cardiovascular Disease, Part 2: Prevention and Treatment of Cardiovascular Disease.

Authors:  Darryl P Leong; Philip G Joseph; Martin McKee; Sonia S Anand; Koon K Teo; Jon-David Schwalm; Salim Yusuf
Journal:  Circ Res       Date:  2017-09-01       Impact factor: 17.367

9.  Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial.

Authors:  Rasha Al-Lamee; David Thompson; Hakim-Moulay Dehbi; Sayan Sen; Kare Tang; John Davies; Thomas Keeble; Michael Mielewczik; Raffi Kaprielian; Iqbal S Malik; Sukhjinder S Nijjer; Ricardo Petraco; Christopher Cook; Yousif Ahmad; James Howard; Christopher Baker; Andrew Sharp; Robert Gerber; Suneel Talwar; Ravi Assomull; Jamil Mayet; Roland Wensel; David Collier; Matthew Shun-Shin; Simon A Thom; Justin E Davies; Darrel P Francis
Journal:  Lancet       Date:  2017-11-02       Impact factor: 79.321

10.  Relationship between Early Physician Follow-Up and 30-Day Readmission after Acute Myocardial Infarction and Heart Failure.

Authors:  Yu-Chi Tung; Guann-Ming Chang; Hsien-Yen Chang; Tsung-Hsien Yu
Journal:  PLoS One       Date:  2017-01-27       Impact factor: 3.240

View more
  1 in total

1.  Impact of Spirometrically Confirmed Chronic Obstructive Pulmonary Disease on Arterial Stiffness and Surfactant Protein D After Percutaneous Coronary Intervention. The CATEPOC Study.

Authors:  Komal Malik; Susana Diaz-Coto; Maria de la Asunción Villaverde; Pablo Martinez-Camblor; Annie Navarro-Rolon; Francisco Pujalte; Alejandro De la Sierra; Pere Almagro
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-10-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.